Diverse role of survival motor neuron protein

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1860, Issue 3, 2017, Pages 299-315

  Singh, Ravindra N ^a   Howell, Matthew D ^a   Ottesen, Eric W ^a   Singh, Natalia N ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Cajal body; DNA repair; Gem; SBP2; Selenoprotein; Signal recognition particle; SMA; SMN; snoRNP biogenesis; snRNP biogenesis; Spinal muscular atrophy; Splicing; Survival Motor Neuron; Telomerase; TERC; TERT; TMG; Transcription

Indexed keywords

DNA; HISTONE MRNA; MESSENGER RNA; RNA; SELENOPROTEIN; SIGNAL RECOGNITION PARTICLE; SMALL NUCLEAR RIBONUCLEOPROTEIN; SMALL NUCLEOLAR RIBONUCLEOPROTEIN; SURVIVAL MOTOR NEURON PROTEIN; UNCLASSIFIED DRUG; SMALL NUCLEAR RNA; SURVIVAL MOTOR NEURON PROTEIN 1;

ACTIN FILAMENT; AMINO TERMINAL SEQUENCE; AMYOTROPHIC LATERAL SCLEROSIS; AUTOPHAGY; CARBOXY TERMINAL SEQUENCE; CELL GRANULE; CELL MIGRATION; DNA RECOMBINATION; DNA REPAIR; ENDOCYTOSIS; HUMAN; INCLUSION BODY MYOSITIS; MALE INFERTILITY; MOLECULAR EVOLUTION; MOLECULAR PATHOLOGY; NERVE DEGENERATION; NONHUMAN; OLIGOMERIZATION; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; RNA METABOLISM; RNA PROCESSING; SIGNAL TRANSDUCTION; SPINAL MUSCULAR ATROPHY; SPLICEOSOME; STRESS GRANULE; TRANSCRIPTION REGULATION; TRANSLATION REGULATION; ANIMAL; COILED BODY; CYTOSKELETON; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEREDITARY SPINAL MUSCULAR ATROPHY; MALE; METABOLISM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; COILED BODIES; CYTOSKELETON; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFERTILITY, MALE; MALE; MYOSITIS, INCLUSION BODY; RNA, SMALL NUCLEAR; SPINAL MUSCULAR ATROPHIES OF CHILDHOOD; SURVIVAL OF MOTOR NEURON 1 PROTEIN;

EID: 85009892763     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2016.12.008     Document Type: Review

References (287)

1. [1] Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., Identification and characterization of a spinal muscular atrophy-determining gene. Cell 80 (1995), 155–165.
2. [2] McAndrew, P.E., Parsons, D.W., Simard, L.R., Rochette, C., Ray, P.N., Mendell, J.R., Prior, T.W., Burghes, A.H., Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am. J. Hum. Genet. 60 (1997), 1411–1422.
3. [3] Wirth, B., An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum. Mutat. 15 (2000), 228–237.
4. [4] Prior, T.W., Spinal muscular atrophy diagnostics. J. Child Neurol. 22 (2007), 952–956.
5. [5] Lorson, C.L., Hahnen, E., Androphy, E.J., Wirth, B., A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc. Natl. Acad. Sci. U. S. A. 11 (1999), 6307–6311.
6. [6] Monani, U.R., Lorson, C.L., Parsons, D.W., Prior, T.W., Androphy, E.J., Burghes, A.H., McPherson, J.D., A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum. Mol. Genet. 8 (1999), 1177–1183.
7. [7] Vitte, J., Fassier, C., Tiziano, F.D., Dalard, C., Soave, S., Roblot, N., Brahe, C., Saugier-Veber, P., Bonnefont, J.P., Melki, J., Refined characterization of the expression and stability of the SMN gene products. Am. J. Pathol. 171 (2007), 1269–1280.
8. [8] Burnett, B.G., Muñoz, E., Tandon, A., Kwon, D.Y., Sumner, C.J., Fischbeck, K.H., Regulation of SMN protein stability. Mol. Cell. Biol. 29 (2009), 1107–1115.
9. [9] Cho, S., Dreyfuss, G., A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev. 24 (2010), 438–442.
10. [10] Le, T.T., Pham, L.T., Butchbach, M.E.R., Zhang, H.L., Monani, U.R., Coovert, D.D., Gavrilina, T.O., Xing, L., Bassell, G.J., Burghes, A.H.M., SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum. Mol. Genet. 14 (2005), 845–857.
11. [11] Schrank, B., Götz, R., Gunnersen, J.M., Ure, J.M., Toyka, K.V., Smith, A.G., Sendtner, M., Inactivation of the survival motor neuron gene, a candidate gene for human spinal muscular atrophy, leads to massive cell death in early mouse embryos. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 9920–9925.
12. [12] Monani, U.R., Sendtner, M., Coovert, D.D., Parsons, D.W., Andreassi, C., Le, T.T., Jablonka, S., Schrank, B., Rossoll, W., Rossol, W., Prior, T.W., Morris, G.E., Burghes, A.H., The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(−/−) mice and results in a mouse with spinal muscular atrophy. Hum. Mol. Genet. 9 (2000), 333–339.
13. [13] Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., Melki, J., Correlation between severity and SMN protein level in spinal muscular atrophy. Nat. Genet. 16 (1997), 265–269.
14. [14] Wirth, B., Brichta, L., Schrank, B., Lochmüller, H., Blick, S., Baasner, A., Heller, R., Mildly affected patients with spinal muscular atrophy are partially protected by an increased SMN2 copy number. Hum. Genet. 119 (2006), 422–428.
15. [15] Oprea, G.E., Kröber, S., McWhorter, M.L., Rossoll, W., Müller, S., Krawczak, M., Bassell, G.J., Beattie, C.E., Wirth, B., Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 320 (2008), 524–527.
16. [16] Amara, A., Adala, L., Ben Charfeddine, I., Mamaï, O., Milli, A., Lazreg, T.B., H'mida, D., Salem, N., Booughammura, L., Saad, A., Gribaa, M., Correlation of SMN2, NAIP, p44, H4F5 and Occludin genes copy number with spinal muscular atrophy phenotype in Tunisian patients. Eur. J. Paediatr. Neurol. 16 (2012), 167–174.
17. [17] Bosch-Marcé, M., Wee, C.D., Martinez, T.L., Lipkes, C.E., Choe, D.W., Kong, L., Van Meerbeke, J.P., Musarò, A., Sumner, C.J., Increased IGF-1 in muscle modulates the phenotype of severe SMA mice. Hum. Mol. Genet. 20 (2011), 1844–1853.
18. [18] Ahmad, S., Wang, Y., Shaik, G.M., Burghes, A.H., Gangwani, L., The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. Hum. Mol. Genet. 21 (2012), 2745–2758.
19. [19] Powis, R.A., Karyka, E., Boyd, P., Côme, J., Jones, R.A., Zheng, Y., Szunyogova, E., Groen, E.J., Hunter, G., Thomson, D., Wishart, T.M., Becker, C.G., Parson, S.H., Martinat, C., Azzouz, M., Gillingwater, T.H., Systemic restoration of UBA1 ameliorates disease in spinal muscular atrophy. JCI Insight, 1, 2016, e87908.
20. [20] Zhang, R., So, B.R., Li, P., Yong, J., Glisovic, T., Wan, L., Dreyfuss, G., Structure of a key intermediate of the SMN complex reveals Gemin2's crucial function in snRNP assembly. Cell 146 (2011), 384–395.
21. [21] Sarachan, K.L., Valentine, K.G., Gupta, K., Moorman, V.R., Gledhill, J.M. Jr., Bernens, M., Tommos, C., Wand, A.J., Duyne, G.D., Solution structure of the core SMN-Gemin2 complex. Biochem. J. 445 (2012), 361–370.
22. [22] Selenko, P., Sprangers, R., Stier, G., Bühler, D., Fischer, U., M Sattler, SMN tudor domain structure and its interaction with the Sm proteins. Nat. Struct. Biol. 8 (2001), 27–31.
23. [23] Sprangers, R., Groves, M.R., Sinning, I., Sattler, M., High-resolution X-ray and NMR structures of the SMN Tudor domain: conformational variation in the binding site for symmetrically dimethylated arginine residues. J. Mol. Biol. 327 (2003), 507–520.
24. [24] 4QQ6, Crystal Structure of Tudor Domain of SMN1 in Complex With a Small Organic Molecule. 2014, 10.2210/pdb4qq6/pdb.
25. [25] Martin, R., Gupta, K., Ninan, N.S., Perry, K., Van Duyne, G.D., The survival motor neuron protein forms soluble glycine zipper oligomers. Structure 20 (2012), 1929–1939.
26. [26] Song, Y., DiMaio, F., Wang, R.Y., Kim, D., Brunette, T., Thompson, J., Baker, D., High-resolution comparative modeling with RosettaCM. Structure 21 (2013), 1735–1742.
27. [27] DeLano, W.L., The PyMOL Molecular Graphics System, Version 1.3. 2010, Schrödinger, LLC.
28. [28] Howell, M.D., Singh, N.N., Singh, R.N., Advances in therapeutic development for spinal muscular atrophy. Future Med. Chem. 6 (2014), 1081–1099.
29. [29] Liu, Q., Dreyfuss, G., A novel nuclear structure containing the survival of motor neurons protein. EMBO J. 15 (1996), 3555–3565.
30. [30] Burlet, P., Huber, C., Bertrandy, S., Ludosky, M.A., Zwaenepoel, I., Clermont, O., Roume, J., Delezoide, A.L., Cartaud, J., Munnich, A., Lefebvre, S., The distribution of SMN protein complex in human fetal tissues and its alteration in spinal muscular atrophy. Hum. Mol. Genet. 7 (1998), 1927–1933.
31. [31] Renvoisé, B., Khoobarry, K., Gendron, M.C., Cibert, C., Viollet, L., Lefebvre, S., Distinct domains of the spinal muscular atrophy protein SMN are required for targeting to Cajal bodies in mammalian cells. J. Cell Sci. 119 (2006), 680–692.
32. [32] Machyna, M., Heyn, P., Neugebauer, K.M., Cajal bodies: where form meets function. Wiley Interdiscip. Rev. RNA 4 (2013), 17–34.
33. [33] Hebert, M.D., Szymczyk, P.W., Shpargel, K.B., Matera, A.G., Coilin forms the bridge between Cajal bodies and SMN, the spinal muscular atrophy protein. Genes Dev. 15 (2001), 2720–2729.
34. [34] Mahmoudi, S., Henriksson, S., Weibrecht, I., Smith, S., Söderberg, O., Strömblad, S., Wiman, K.G., Farnebo, M., WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies. PLoS Biol., 8, 2010, e1000521.
35. [35] Zhang, H., Xing, L., Singer, R.H., Bassell, G.J., QNQKE targeting motif for the SMN-Gemin multiprotein complexin neurons. J. Neurosci. Res. 85 (2007), 2657–2667.
36. [36] Walker, M.P., Rajendra, T.K., Saieva, L., Fuentes, J.L., Pellizzoni, L., Matera, A.G., SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Hum. Mol. Genet. 17 (2008), 3399–3410.
37. [37] Pagliardini, S., Giavazzi, A., Setola, V., Lizier, C., Di Luca, M., DeBiasi, S., Battaglia, G., Subcellular localization and axonal transport of the survival motor neuron (SMN) protein in the developing rat spinal cord. Hum. Mol. Genet. 9 (2000), 47–56.
38. [38] Zhang, H.L., Pan, F., Hong, D., Shenoy, S.M., Singer, R.H., Bassell, G.J., Active transport of the survival motor neuron protein and the role of exon-7 in cytoplasmic localization. J. Neurosci. 23 (2003), 6627–6637.
39. [39] Fallini, C., Bassell, G.J., Rossoll, W., Spinal muscular atrophy: the role of SMN in axonal mRNA regulation. Brain Res. 1462 (2012), 81–92.
40. [40] Rossoll, W., Jablonka, S., Andreassi, C., Kröning, A.-K., Karle, K., Monani, U.R., Sendtner, M., Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of beta-actin mRNA in growth cones of motoneurons. J. Cell Biol. 163 (2003), 801–812.
41. [41] Zhang, H., Xing, L., Rossoll, W., Wichterle, H., Singer, R.H., Bassell, G.J., Multiprotein complexes of the survival of motor neuron protein SMN with Gemins traffic to neuronal processes and growth cones of motor neurons. J. Neurosci. 26 (2006), 8622–8632.
42. [42] Todd, A.G., Morse, R., Shaw, D.J., McGinley, S., Stebbings, H., Young, P.J., SMN, Gemin2 and Gemin3 associate with beta-actin mRNA in the cytoplasm of neuronal cells in vitro. J. Mol. Biol. 401 (2010), 681–689.
43. [43] Peter, C.J., Evans, M., Thayanithy, V., Taniguchi-Ishigaki, N., Bach, I., Kolpak, A., Bassell, G.J., Rossoll, W., Lorson, C.L., Bao, Z.-Z., Androphy, E.J., The COPI vesicle complex binds and moves with survival motor neuron within axons. Hum. Mol. Genet. 20 (2011), 1701–1711.
44. [44] Ting, C.-H., Wen, H.-L., Liu, H.-C., Hsieh-Li, H.-M., Li, H., Lin-Chao, S., The spinal muscular atrophy disease protein SMN is linked to the Golgi network. PLoS One, 7, 2012, e51826.
45. [45] Torres-Benito, L., Neher, M.F., Cano, R., Ruiz, R., Tabares, L., SMN requirement for synaptic vesicle, active zone and microtubule postnatal organization in motor nerve terminals. PLoS One, 6, 2011, e26164.
46. [46] Zou, T., Yang, X., Pan, D., Huang, J., Sahin, M., Zhou, J., SMN deficiency reduces cellular ability to form stress granules, sensitizing cells to stress. Cell. Mol. Neurobiol. 31 (2011), 541–550.
47. [47] Setola, V., Terao, M., Locatelli, D., Bassanini, S., Garattini, E., Battaglia, G., Axonal-SMN (a-SMN), a protein isoform of the survival motor neuron gene, is specifically involved in axonogenesis. Proc. Natl. Acad. Sci. U. S. A. 104 (2007), 1959–1964.
48. [48] Singh, N.N., Seo, J., Rahn, S.J., Singh, R.N., A multi-exon-skipping detection assay reveals surprising diversity of splice isoforms of spinal muscular atrophy genes. PLoS One, 7, 2012, e49595.
49. [49] Seo, J., Singh, N.N., Ottesen, E.W., Sivanesan, S., Shishimorova, M., Singh, R.N., Oxidative stress triggers body-wide skipping of multiple exons of spinal muscular atrophy gene. PLoS One, 11, 2016, e0154390.
50. [50] Seo, J., Singh, N.N., Ottesen, E.W., Lee, B.M., Singh, R.N., A novel human-specific splice isoform alters the critical C-terminus of Survival Motor Neuron protein. Sci. Rep., 6, 2016, 30778.
51. [51] Locatelli, D., Terao, M., Fratelli, M., Zanetti, A., Kurosaki, M., Lupi, M., Barzago, M.M., Uggetti, A., Capra, S., D'Errico, P., Battaglia, G.S., Garattini, E., Human axonal survival of motor neuron (a-SMN) protein stimulates axon growth, cell motility, C-C motif ligand 2 (CCL2), and insulin-like growth factor-1 (IGF1) production. J. Biol. Chem. 287 (2012), 25782–25794.
52. [52] Broccolini, A., Engel, W.K., Alvarez, R.B., Askanas, V., Paired helical filaments of inclusion-body myositis muscle contain RNA and survival motor neuron protein. Am. J. Pathol. 156 (2000), 1151–1155.
53. [53] Achsel, T., Barabino, S., Cozzolino, M., Carrì, M.T., The intriguing case of motor neuron disease: ALS and SMA come closer. Biochem. Soc. Trans. 41 (2013), 1593–1597.
54. [54] Cucchiarini, M., Madry, H., Terwilliger, E.F., Enhanced expression of the central survival of motor neuron (SMN) protein during the pathogenesis of osteoarthritis. J. Cell. Mol. Med. 18 (2014), 115–124.
55. [55] Chen, H.-H., Chang, J.-G., Lu, R.-M., Peng, T.-Y., Tarn, W.-Y., The RNA binding protein hnRNP Q modulates the utilization of exon 7 in the survival motor neuron 2 (SMN2) Gene. Mol. Cell. Biol. 28 (2008), 6929–6938.
56. [56] Chen, Y.-C., Chang, J.-G., Jong, Y.-J., Liu, T.-Y., You, C.-Y., High expression level of Tra2-β1 is responsible for increased SMN2 exon 7 inclusion in the testis of SMA mice. PLoS One, 10, 2015, e0120721.
57. [57] Ottesen, E.W., Howell, M.D., Singh, N.N., Seo, J., Whitley, E.M., Singh, R.N., Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy. Sci. Rep., 6, 2016, 20193.
58. [58] Seo, J., Howell, M.D., Singh, N.N., Singh, R.N., Spinal muscular atrophy: an update on therapeutic progress. Biochim. Biophys. Acta 1832 (2013), 2180–2190.
59. [59] Singh, N.K., Singh, N.N., Androphy, E.J., Singh, R.N., Splicing of a critical exon of human Survival Motor Neuron is regulated by a unique silencer element located in the last intron. Mol. Cell. Biol. 26 (2006), 1333–1346.
60. [60] Porensky, P.N., Burghes, A.H.M., Antisense oligonucleotides for the treatment of spinal muscular atrophy. Hum. Gene Ther. 24 (2013), 489–498.
61. [61] Sivanesan, S., Howell, M.D., DiDonato, C.J., Singh, R.N., Antisense oligonucleotide mediated therapy of spinal muscular atrophy. Transl. Neurosci. 4 (2013), 1–7.
62. [62] Singh, N.N., Lee, B.M., DiDonato, C.J., Singh, R.N., Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy. Future Med. Chem. 7 (2015), 1793–1808.
63. [63] Awano, T., Kim, J.K., Monani, U.R., Spinal muscular atrophy: journeying from bench to bedside. Neurotherapeutics 11 (2014), 786–795.
64. [64] Faravelli, I., Nizzardo, M., Comi, G.P., Corti, S., Spinal muscular atrophy—recent therapeutic advances for an old challenge. Nat. Rev. Neurol. 11 (2015), 351–359.
65. [65] Wirth, B., Barkats, M., Martinat, C., Sendtner, M., Gillingwater, T.H., Moving towards treatments for spinal muscular atrophy: hopes and limits. Expert Opin. Emerg. Drugs 20 (2015), 353–356.
66. [66] Ahmad, S., Bhatia, K., Kannan, A., Gangwani, L., Molecular mechanisms of neurodegeneration in spinal muscular atrophy. J. Exp. Neurosci. 10 (2016), 39–49.
67. [67] Van Alstyne, M., Pellizzoni, L., Advances in modeling and treating spinal muscular atrophy. Curr. Opin. Neurol. 29 (2016), 549–556.
68. [68] Singh, R.N., Evolving concepts on human SMN pre-mRNA splicing. RNA Biol. 4 (2007), 7–10.
69. [69] Singh, N.N., Singh, R.N., Alternative splicing in spinal muscular atrophy underscores the role of an intron definition model. RNA Biol. 8 (2011), 600–606.
70. [70] Singh, N.N., Lee, B.M., Singh, R.N., Splicing regulation in spinal muscular atrophy by an RNA structure formed by long-distance interactions. Ann. N. Y. Acad. Sci. 1341:2015 (2015), 176–187.
71. [71] Singh, N.N., Howell, M.D., Singh, R.N., Transcription and splicing regulation of spinal muscular atrophy genes. Sumner, C.J., Paushkin, S., Ko, C.-P., (eds.) Spinal Muscular Atrophy: Disease Mechanisms and Therapy, 2017, Academic Press, London, 75–97.
72. [72] Liu, Q., Fischer, U., Wang, F., Dreyfuss, G., The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell 19 (1997), 1013–1021.
73. [73] Lorson, C.L., Androphy, E.J., The domain encoded by exon 2 of the survival motor neuron protein mediates nucleic acid binding. Hum. Mol. Genet. 7 (1998), 1269–1275.
74. [74] Bertrandy, S., Burlet, P., Clermont, O., Huber, C., Fondrat, C., Thierry-Mieg, D., Munnich, A., Lefebvre, S., The RNA-binding properties of SMN: deletion analysis of the zebrafish orthologue defines domains conserved in evolution. Hum. Mol. Genet. 8 (1999), 775–782.
75. [75] Takaku, M., Tsujita, T., Horikoshi, N., Takizawa, Y., Qing, Y., Hirota, K., Ikura, M., Takeda, S., Kurumizaka, H., Purification of the human SMN-GEMIN2 complex and assessment of its stimulation of RAD51-mediated DNA recombination reactions. Biochemistry 50 (2011), 6797–6805.
76. [76] Piazzon, N., Schlotter, F., Lefebvre, S., Dodré, M., Méreau, A., Soret, J., Besse, A., Barkatas, M., Bordonné, R., Branlant, C., Massenet, S., Implication of the SMN complex in the biogenesis and steady state level of the Signal Recognition Particle. Nucleic Acids Res. 41 (2013), 1255–1272.
77. [77] Sanchez, G., Dury, A.Y., Murray, L.M., Biondi, O., Tadesse, H., El Fatimy, R., Kothary, R., Charbonnier, F., Khandijan, E.W., Côté, J., A novel function for the survival motoneuron protein as a translational regulator. Hum. Mol. Genet. 22 (2013), 668–684.
78. [78] Young, P.J., Day, P.M., Zhou, J., Androphy, E.J., Morris, G.E., Lorson, C.L., A direct interaction between the survival motor neuron protein and p53 and its relationship to spinal muscular atrophy. J. Biol. Chem. 277 (2002), 2852–2859.
79. [79] Côté, J., Richard, S., Tudor domains bind symmetrical dimethylated arginines. J. Biol. Chem. 280 (2005), 28476–28483.
80. [80] Tripsianes, K., Madl, T., Machyna, M., Fessas, D., Englbrecht, C., Fischer, U., Neugebauer, K.M., Sattler, M., Structural basis for dimethylarginine recognition by the Tudor domains of human SMN and SPF30 proteins. Nat. Struct. Mol. Biol. 20 (2011), 1414–1420.
81. [81] Thandapani, P., O'Connor, T.R., Bailey, T.L., Richard, S., Defining the RGG/RG motif. Mol. Cell 6 (2013), 613–623.
82. [82] Pellizzoni, L., Baccon, J., Charroux, B., Dreyfuss, G., The survival of motor neurons (SMN) protein interacts with the snoRNP proteins fibrillarin and GAR1. Curr. Biol. 21 (2001), 1079–1088.
83. [83] Whitehead, S.E., Jones, K.W., Zhang, X., Cheng, X., Terns, R.M., Terns, M.P., Determinants of the interaction of the spinal muscular atrophy disease protein SMN with the dimethylarginine-modified box H/ACA small nucleolar ribonucleoprotein GAR1. J. Biol. Chem. 277 (2002), 48087–48093.
84. [84] Mourelatos, Z., Abel, L., Yong, J., Kataoka, N., Dreyfuss, G., SMN interacts with a novel family of hnRNP and spliceosomal proteins. EMBO J. 20 (2001), 5443–5452.
85. [85] Rossoll, W., Kröning, A.K., Ohndorf, U.M., Steegborn, C., Jablonka, S., Sendtner, M., Specific interaction of Smn, the spinal muscular atrophy determining gene product, with hnRNP-R and gry-rbp/hnRNP-Q: a role for Smn in RNA processing in motor axons?. Hum. Mol. Genet. 11 (2002), 93–105.
86. [86] Young, P.J., Francis, J.W., Lince, D., Coon, K., Androphy, E.J., Lorson, C.L., The Ewing's sarcoma protein interacts with the Tudor domain of the survival motor neuron protein. Brain Res. Mol. Brain Res. 119 (2003), 37–49.
87. [87] Piazzon, N., Rage, F., Schlotter, F., Moine, H., Branlant, C., Massenet, S., In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile X mental retardation protein. J. Biol. Chem. 283 (2008), 5598–5610.
88. [88] Yamazaki, T., Chen, S., Yu, Y., Yan, B., Haertlein, T.C., Carrasco, M.A., Tapia, J.C., Zhai, B., Das, R., Lalancette-Hebert, M., Sharma, A., Chandran, S., Sullivan, G., Nishimura, A.L., Shaw, C.E., Gygi, S.P., Shneider, N.A., Maniatis, T., Reed, R., FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 2 (2012), 799–806.
89. [89] Sabra, M., Texier, P., El Maalouf, J., Lomonte, P., The Tudor protein survival motor neuron (SMN) is a chromatin-binding protein that interacts with methylated lysine 79 of histone H3. J. Cell Sci. 126 (2013), 3664–3677.
90. [90] Zhao, D.Y., Gish, G., Braunschweig, U., Li, Y., Ni, Z., Schmitges, F.W., Zhong, G., Liu, K., Li, W., Moffat, J., Vedadi, M., Min, J., Pawson, T.J., Blencowe, B.J., Greenblatt, J.F., SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination. Nature 529 (2016), 48–53.
91. [91] Fuller, H.R., Man, N.T., Lam le, T., Thanh le, T., Keough, R.A., Asperger, A., Gonda, T.J., Morris, G.E., The SMN interactome includes Myb-binding protein 1a. J. Proteome Res. 9 (2010), 556–563.
92. [92] Shafey, D., Boyer, J.G., Bhanot, K., Kothary, R., Identification of novel interacting protein partners of SMN using tandem affinity purification. J. Proteome Res. 9 (2010), 1659–1669.
93. [93] Giesemann, T., Rathke-Hartlieb, S., Rothkegel, M., Bartsch, J.W., Buchmeier, S., Jockusch, B.M., Jockusch, H., A role for polyproline motifs in the spinal muscular atrophy protein SMN. Profilins bind to and colocalize with smn in nuclear gems. J. Biol. Chem. 274 (1999), 37908–37914.
94. [94] Lorson, C.L., Strasswimmer, J., Yao, J.M., Baleja, J.D., Hahnen, E., Wirth, B., Le, T., Burghes, A.H., Androphy, E.J., SMN oligomerization defect correlates with spinal muscular atrophy severity. Nat. Genet. 19 (1998), 63–66.
95. [95] Narayanan, U., Achsel, T., Lührmann, R., Matera, A.G., Coupled in vitro import of U snRNPs and SMN, the spinal muscular atrophy protein. Mol. Cell 16 (2004), 223–234.
96. [96] Charroux, B., Pellizzoni, L., Perkinson, R.A., Shevchenko, A., Mann, M., Dreyfuss, G., Gemin3: a novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J. Cell Biol. 147 (1999), 1181–1193.
97. [97] Gangwani, L., Mikrut, M., Theroux, S., Sharma, M., Davis, R.J., Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein. Nat. Cell Biol. 3 (2001), 376–383.
98. [98] Zou, J., Barahmand-pour, F., Blackburn, M.L., Matsui, Y., Chansky, H.A., Yang, L., Survival motor neuron (SMN) protein interacts with transcription corepressor mSin3A. J. Biol. Chem. 279 (2004), 14922–14928.
99. [99] Mouaikel, J., Narayanan, U., Verheggen, C., Matera, A.G., Bertrand, E., Tazi, J., Bordonné, R., Interaction between the small-nuclear-RNA cap hypermethylase and the spinal muscular atrophy protein, survival of motor neuron. EMBO Rep. 4 (2003), 616–622.
100. [100] Wurth, L., Gribling-Burrer, A.S., Verheggen, C., Leichter, M., Takeuchi, A., Baudrey, S., Martin, F., Krol, A., Bertrand, E., Allmang, C., Hypermethylated-capped selenoprotein mRNAs in mammals. Nucleic Acids Res. 42 (2014), 8663–8677.
101. [101] Carrel, T.L., McWhorter, M.L., Workman, E., Zhang, H., Wolstencroft, E.C., Lorson, C., Bassell, G.J., Burghes, A.H., Beattie, C.E., Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J. Neurosci. 26 (2006), 11014–11022.
102. [102] Mattis, V.B., Ebert, A.D., Fosso, M.Y., Chang, C.W., Lorson, C.L., Delivery of a read-through inducing compound, TC007, lessens the severity of a spinal muscular atrophy animal model. Hum. Mol. Genet. 18 (2009), 3906–3913.
103. [103] Heier, C.R., DiDonato, C.J., Translational readthrough by the aminoglycoside geneticin (G418) modulates SMN stability in vitro and improves motor function in SMA mice in vivo. Hum. Mol. Genet. 18 (2009), 1310–1322.
104. [104] Paushkin, S., Charroux, B., Abel, L., Perkinson, R.A., Pellizzoni, L., Dreyfuss, G., The survival motor neuron protein of Schizosacharomyces pombe. Conservation of survival motor neuron interaction domains in divergent organisms. J. Biol. Chem. 275 (2000), 23841–23846.
105. [105] Schlaen, R.G., Mancini, E., Sanchez, S.E., Perez-Santángelo, S., Rugnone, M.L., Simpson, C.G., Brown, J.W., Zhang, X., Chernomoretz, A., Yanovsky, M.J., The spliceosome assembly factor GEMIN2 attenuates the effects of temperature on alternative splicing and circadian rhythms. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 9382–9387.
106. [106] Pellizzoni, L., Kataoka, N., Charroux, B., Dreyfuss, G., A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing. Cell 95 (1998), 615–624.
107. [107] Bachand, F., Boisvert, F.M., Côté, J., Richard, S., Autexier, C., The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein. Mol. Biol. Cell 13 (2002), 3192–3202.
108. [108] Fischer, U., Liu, Q., Dreyfuss, G., The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis. Cell 19 (1997), 1023–1029.
109. [109] Pellizzoni, L., Yong, J., Dreyfuss, G., Essential role for the SMN complex in the specificity of snRNP assembly. Science 298 (2002), 1775–1779.
110. [110] Battle, D.J., Lau, C.K., Wan, L., Deng, H., Lotti, F., Dreyfuss, G., The Gemin5 protein of the SMN complex identifies snRNAs. Mol. Cell 23 (2006), 273–279.
111. [111] Wan, L., Ottinger, E., Cho, S., Dreyfuss, G., Inactivation of the SMN complex by oxidative stress. Mol. Cell 31 (2008), 244–254.
112. [112] So, B.R., Wan, L., Zhang, Z., Li, P., Babiash, E., Duan, J., Younis, I., Dreyfuss, G., A U1 snRNP-specific assembly pathway reveals the SMN complex as a versatile hub for RNP exchange. Nat. Struct. Mol. Biol. 23 (2016), 225–230.
113. [113] Gubitz, A.K., Feng, W., Dreyfuss, G., The SMN complex. Exp. Cell Res. 296 (2004), 51–56.
114. [114] Kolb, S.J., Battle, D.J., Dreyfuss, G., Molecular functions of the SMN complex. J. Child Neurol. 22 (2007), 990–994.
115. [115] Li, D.K., Tisdale, S., Lotti, F., Pellizzoni, L., SMN control of RNP assembly: from post-transcriptional gene regulation to motor neuron disease. Semin. Cell Dev. Biol. 32 (2014), 22–29.
116. [116] Pillai, R.S., Grimmler, M., Meister, G., Will, C.L., Lührmann, R., Fischer, U., Schümperli, D., Unique Sm core structure of U7 snRNPs: assembly by a specialized SMN complex and the role of a new component, Lsm11, in histone RNA processing. Genes Dev. 17 (2003), 2321–2333.
117. [117] Tisdale, S., Lotti, F., Saieva, L., Van Meerbeke, J.P., Crawford, T.O., Sumner, C.J., Mentis, G.Z., Pellizzoni, L., SMN is essential for the biogenesis of U7 small nuclear ribonucleoprotein and 3'-end formation of histone mRNAs. Cell Rep. 5 (2013), 1187–1195.
118. [118] Jones, K.W., Gorzynski, K., Hales, C.M., Fischer, U., Badbanchi, F., Tern, R.M., Terns, M.P., Direct interaction of the spinal muscular atrophy disease protein SMN with the small nucleolar RNA-associated protein fibrillarin. J. Biol. Chem. 276 (2001), 38645–38651.
119. [119] Poole, A.R., Hebert, M.D., SMN and coilin negatively regulate dyskerin association with telomerase RNA. Biol. Open 5 (2016), 726–735.
120. [120] Hua, Y., Zhou, J., Survival motor neuron protein facilitates assembly of stress granules. FEBS Lett. 572 (2004), 69–74.
121. [121] Sanchez, G., Dury, A.Y., Murray, L.M., Biondi, O., Tadesse, H., El Fatimy, R., Kothary, R., Charbonnier, F., Khandjian, E.W., Côté, J., A novel function for the survival motoneuron protein as a translational regulator. Hum. Mol. Genet. 22 (2012), 668–684.
122. [122] Sanchez, G., Bondy-Chorney, E., Laframboise, J., Paris, G., Didillon, A., Jasmin, B.J., Côté, J., A novel role for CARM1 in promoting nonsense-mediated mRNA decay: potential implications for spinal muscular atrophy. Nucleic Acids Res. 44 (2016), 2661–2676.
123. [123] Dombert, B., Sivadasan, R., Simon, C.M., Jablonka, S., Sendtner, M., Presynaptic localization of Smn and hnRNP R in axon terminals of embryonic and postnatal mouse motoneurons. Plos One, 9, 2014, e110846.
124. [124] Tadesse, H., Deschênes-Furry, J., Boisvenue, S., Côté, J., KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy. Hum. Mol. Genet. 17 (2008), 506–524.
125. [125] Hubers, L., Valderrama-Carvajal, H., Laframboise, J., Timbers, J., Sanchez, G., Côté, J., HuD interacts with survival motor neuron protein and can rescue spinal muscular atrophy-like neuronal defects. Hum. Mol. Genet. 20 (2011), 553–579.
126. [126] Fallini, C., Zhang, H.L., Su, Y.H., Silani, V., Singer, R.H., Rossoll, W., Bassell, G.J., The Survival of Motor Neuron (SMN) protein interacts with the mRNA-binding protein HuD and regulates localization of poly(A) mRNA in primary motor neuron axons. J. Neurosci. 21 (2011), 3914–3925.
127. [127] Akten, B., Kye, M.J., Hao, L.T., Wertz, M.H., Singh, S., Nie, D.Y., Huang, J., Merianda, T.T., Twiss, J.L., Beattie, C.E., Steen, J.A., Sahin, M., Interaction of survival of motor neuron (SMN) and HuD proteins with mRNA cpg15 rescues motor neuron axonal deficits. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 10337–10342.
128. [128] Rage, F., Boulisfane, N., Rihan, K., Neel, H., Gostan, T., Bertrand, E., Bordonné, R., Soret, J., Genome-wide identification of mRNAs associated with the protein SMN whose depletion decreases their axonal localization. RNA 19 (2013), 1755–1766.
129. [129] Fallini, C., Rouanet, J.P., Donlin-Asp, P.G., Guo, P., Zhang, H.L., Singer, R.H., Rossoll, W., Bassell, G.J., Dynamics of Survival of Motor Neuron (SMN) protein interaction with the mRNA-binding protein IMP1 facilitates its trafficking into motor neuron axons. Dev. Neurobiol. 74 (2014), 319–332.
130. [130] Fallini, C., Donlin-Asp, P.G., Rouanet, J.P., Bassell, G.J., Rossoll, W., Deficiency of the survival of motor neuron protein impairs mRNA localization and local translation in the growth cone of motor neurons. J. Neurosci. 36 (2016), 3811–3820.
131. [131] Pellizzoni, L., Baccon, J., Rappsilber, J., Mann, M., Dreyfuss, G., Purification of native survival of motor neurons complexes and identification of Gemin6 as a novel component. J. Biol. Chem. 277 (2002), 7540–7545.
132. [132] Fischer, U., Englbrecht, C., Chari, A., Biogenesis of spliceosomal small nuclear ribonucleoproteins. Wiley Interdiscip. Rev. RNA 2 (2011), 718–731.
133. [133] Hallais, M., Pontvianne, F., Andersen, P.R., Clerici, M., Lener, D., Benbahouche, H., Gostan, T., Vandermoere, F., Robert, M.C., Cusack, S., Verheggen, C., Jensen, T.H., Bertrand, E., CBC-ARS2 stimulates 3'-end maturation of multiple RNA families and favors cap-proximal processing. Nat. Struct. Mol. Biol. 20 (2013), 1358–1366.
134. [134] Izumi, H., McCloskey, A., Shinmyozu, K., Ohno, M., p54nrb/NonO and PSF promote U snRNA nuclear export by accelerating its export complex assembly. Nucleic Acids Res. 42 (2014), 3998–4007.
135. [135] Mouaikel, J., Verheggen, C., Bertrand, E., Tazi, J., Bordonné, R., Hypermethylation of the cap structure of both yeast snRNAs and snoRNAs requires a conserved methyltransferase that is localized to the nucleolus. Mol. Cell 9 (2002), 891–901.
136. [136] Borg, R.M., Fenech Salerno, B., Vassallo, N., Bordonne, R., Cauchi, R.J., Disruption of snRNP biogenesis factors Tgs1 and pICln induces phenotypes that mirror aspects of SMN-Gemins complex perturbation in Drosophila, providing new insights into spinal muscular atrophy. Neurobiol. Dis. 94 (2016), 245–258.
137. [137] Hamm, J., Darzynkiewicz, E., Tahara, S.M., Mattaj, I.W., The trimethylguanosine cap structure of U1 snRNA is a component of a bipartite nuclear targeting signal. Cell 62 (1990), 569–577.
138. [138] Fischer, U., Lührmann, R., An essential signaling role for the m3G cap in the transport of U1 snRNP to the nucleus. Science 249 (1990), 786–790.
139. [139] Fischer, U., Sumpter, V., Sekine, M., Satoh, T., Luhrmann, R., Nucleo-cytoplasmic transport of U snRNPs: definition of a nuclear location signal in the Sm core domain that binds a transport receptor independently of the m3G cap. EMBO J. 12 (1993), 573–583.
140. [140] Henriksson, S., Farnebo, M., On the road with WRAP53β: guardian of Cajal bodies and genome integrity. Front. Genet., 6, 2015, 91.
141. [141] Olaso, R., Joshi, V., Fernandez, J., Roblot, N., Courageot, S., Bonnefont, J.P., Melki, J., Activation of RNA metabolism-related genes in mouse but not human tissues deficient in SMN. Physiol. Genomics 24 (2006), 97–104.
142. [142] Zhang, Z., Lotti, F., Dittmar, K., Younis, I., Wan, L., Kasim, M., Dreyfuss, G., SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 133 (2008), 585–600.
143. [143] Bäumer, D., Lee, S., Nicholson, G., Davies, J.L., Parkinson, N.J., Murray, L.M., Gillingwater, T.H., Ansorge, O., Davies, K.E., Talbot, K., Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy. PLoS Genet., 5, 2009, e1000773.
144. [144] Campion, Y., Neel, H., Gostan, T., Soret, J., Bordonné, R., Specific splicing defects in S. pombe carrying a degron allele of the Survival of Motor Neuron gene. EMBO J. 29 (2010), 1817–1829.
145. [145] Maeda, M., Harris, A.W., Kingham, B.F., Lumpkin, C.J., Opdenaker, L.M., McCahan, S.M., Wang, W., Butchbach, M.E., Transcriptome profiling of spinal muscular atrophy motor neurons derived from mouse embryonic stem cells. PLoS One, 9, 2014, e106818.
146. [146] Lotti, F., Imlach, W.L., Saieva, L., Beck, E.S., Hao, L.T., Li, D.K., Jiao, W., Mentis, G.Z., Beattie, C.E., McCabe, B.D., Pellizzoni, L., An SMN-dependent U12 splicing event essential for motor circuit function. Cell 151 (2012), 440–454.
147. [147] Reichow, S.L., Hamma, T., Ferré-D'Amaré, A.R., Varani, G., The structure and function of small nucleolar ribonucleoproteins. Nucleic Acids Res. 35 (2007), 1452–1464.
148. [148] Lui, L., Lowe, T., Small nucleolar RNAs and RNA-guided post-transcriptional modification. Essays Biochem. 254 (2013), 53–77.
149. [149] Jorjani, H., Kehr, S., Jedlinski, D.J., Gumienny, R., Hertel, J., Stadler, P.F., Zavolan, M., Gruber, A.R., An updated human snoRNAome. Nucleic Acids Res. 44 (2016), 5068–5082.
150. [150] Francis, J.W., Sandrock, A.W., Bhide, P.G., Vonsattel, J.P., Brown, R.H. Jr., Heterogeneity of subcellular localization and electrophoretic mobility of survival motor neuron (SMN) protein in mammalian neural cells and tissues. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 6492–6497.
151. [151] Young, P.J., Le, T.T., thiMan, N., Burghes, A.H., Morris, G.E., The relationship between SMN, the spinal muscular atrophy protein, and nuclear coiled bodies in differentiated tissues and cultured cells. Exp. Cell Res. 256 (2000), 365–374.
152. [152] Young, P.J., Le, T.T., Dunckley, M., Nguyen, T.M., Burghes, A.H., Morris, G.E., Nuclear gems and Cajal (coiled) bodies in fetal tissues: nucleolar distribution of the spinal muscular atrophy protein, SMN. Exp. Cell Res. 265 (2001), 252–261.
153. [153] Darzacq, X., Jády, B.E., Verheggen, C., Kiss, A.M., Bertrand, E., Kiss, T., Cajal body-specific small nuclear RNAs: a novel class of 2'-O-methylation and pseudouridylation guide RNAs. EMBO J. 21 (2000), 2746–2756.
154. [154] Richard, P., Darzacq, X., Bertrand, E., Jády, B.E., Verheggen, C., Kiss, T., A common sequence motif determines the Cajal body-specific localization of box H/ACA scaRNAs. EMBO J. 22 (2003), 4283–4293.
155. [155] Tycowski, K.T., Shu, M.D., Kukoyi, A., Steitz, J.A., A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles, Mol. Cell 34 (2009), 47–57.
156. [156] Marnef, A., Richard, P., Pinzón, N., Kiss, T., Targeting vertebrate intron-encoded box C/D 2'-O-methylation guide RNAs into the Cajal body. Nucleic Acids Res. 42 (2014), 6616–6629.
157. [157] Renvoisé, B., Colasse, S., Burlet, P., Viollet, L., Meier, U.T., Lefebvre, S., The loss of the snoRNP chaperone Nopp140 from Cajal bodies of patient fibroblasts correlates with the severity of spinal muscular atrophy. Hum. Mol. Genet. 18 (2009), 1181–1189.
158. [158] Zhang, Q., Kim, N.K., Feigon, J., Architecture of human telomerase RNA. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 20325–20332.
159. [159] Tseng, C.K., Wang, H.F., Burns, A.M., Schroeder, M.R., Gaspari, M., Baumann, P., Human telomerase RNA processing and quality control. Cell Rep. 13 (2015), 2232–2243.
160. [160] Venteicher, A.S., Abreu, E.B., Meng, Z., Mccann, K.E., Terns, R.M., Veenstra, T.D., Terns, M.P., Artandi, S.E., A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323 (2009), 644–648.
161. [161] Marzluff, W.F., Wagner, E.J., Duronio, R.J., Metabolism and regulation of canonical histone mRNAs: life without a poly(A) tail. Nat. Rev. Genet. 9 (2008), 843–854.
162. [162] Pillai, R.S., Will, C.L., Lührmann, R., Schümperli, D., Müller, B., Purified U7 snRNPs lack the Sm proteins D1 and D2 but contain Lsm10, a new 14 kDa Sm D1-like protein. EMBO J. 20 (2001), 5470–5479.
163. [163] Makarov, E.M., Owen, N., Bottrill, A., Makarova, O.V., Functional mammalian spliceosomal complex E contains SMN complex proteins in addition to U1 and U2 snRNPs. Nucleic Acids Res. 40 (2012), 2639–2652.
164. [164] Jarmoskaite, I., Russell, R., RNA helicase proteins as chaperones and remodelers. Annu. Rev. Biochem. 83 (2014), 697–725.
165. [165] Singh, N.N., Androphy, E.J., Singh, R.N., An extended inhibitory context causes skipping of exon 7 of SMN2 in spinal muscular atrophy. Biochem. Biophys. Res. Commun. 315 (2004), 381–388.
166. [166] Singh, N.N., Androphy, E.J., Singh, R.N., Regulation and regulatory activities of alternative splicing of the SMN genes. Crit. Rev. Eukaryot. Gene Expr. 14 (2004), 271–285.
167. [167] Buratti, E., Dhir, A., Lewandowska, M.A., Baralle, F.E., RNA structure is a key regulatory element in pathological ATM and CFTR pseudoexon inclusion events. Nucleic Acids Res. 35 (2007), 4369–4383.
168. [168] Singh, N.N., Singh, R.N., Androphy, E.J., Modulating role of a RNA structure in skipping of a critical exon in the spinal muscular atrophy genes. Nucleic Acids Res. 35 (2007), 371–389.
169. [169] Shepard, P.J., Hertel, K.J., Conserved RNA secondary structures promote alternative splicing. RNA 14 (2008), 1463–1469.
170. [170] Warf, M.B., Berglund, J.A., Role of RNA structure in regulating pre-mRNA splicing. Trends Biochem. Sci. 35 (2010), 169–178.
171. [171] Singh, N.N., Lawler, M.N., Ottesen, E.W., Upreti, D., Kaczynski, J.R., Singh, R.N., An intronic structure enabled by a long-distance interaction serves as a novel target for splicing correction in spinal muscular atrophy. Nucleic Acids Res. 41 (2013), 8144–8165.
172. [172] Singh, N.N., Androphy, E.J., Singh, R.N., In vivo selection reveals features of combinatorial control that defines a critical exon in the spinal muscular atrophy genes. RNA 10 (2004), 1291–1305.
173. [173] Singh, R.N., Unfolding the mystery of alternative splicing through a unique method of in vivo selection. Front. Biosci. 12 (2007), 3263–3272.
174. [174] Cartegni, L., Krainer, A.R., Correction of disease-associated exon skipping by synthetic exon-specific activators. Nat. Struct. Biol. 10 (2003), 120–125.
175. [175] Hua, Y., Vickers, T.A., Baker, B.F., Bennett, C.F., Krainer, A.R., Enhancement of SMN2 exon 7 inclusion by antisense oligonucleotides targeting the exon. PLoS Biol., 5, 2007, e73.
176. [176] Singh, N.N., Shishimorova, M., Cao, L.C., Gangwani, L., Singh, R.N., A short antisense oligonucleotide masking a unique intronic motif prevents skipping of a critical exon in spinal muscular atrophy. RNA Biol. 6 (2009), 341–350.
177. [177] Geib, T., Hertel, K.J., Restoration of full-length SMN promoted by adenoviral vectors expressing RNA antisense oligonucleotides embedded in U7 snRNAs. PLoS One, 4, 2009, e8204.
178. [178] Singh, N.N., Hollinger, K., Bhattacharya, D., Singh, R.N., An antisense microwalk reveals critical role of an intronic position linked to a unique long-distance interaction in pre mRNA splicing. RNA 16 (2010), 1167–1181.
179. [179] Owen, N., Zhou, H., Malygin, A.A., Sangha, J., Smith, L.D., Muntoni, F., Eperon, I.C., Design principles for bifunctional targeted oligonucleotide enhancers of splicing. Nucleic Acids Res. 39 (2011), 7194–7208.
180. [180] Osman, E.Y., Yen, P.F., Lorson, C.L., Bifunctional RNAs targeting the intronic splicing silencer N1 increase SMN levels and reduce disease severity in an animal model of spinal muscular atrophy. Mol. Ther. 20 (2012), 119–126.
181. [181] Kiel, J.M., Seo, J., Howell, M.D., Hsu, W.H., Singh, R.N., DiDonato, C.J., A short antisense oligonucleotide ameliorates symptoms of severe mouse models of spinal muscular atrophy. Mol. Ther.–Nucleic Acids, 3, 2014, e174.
182. [182] Pao, P.W., Wee, K.B., Yee, W.C., Pramono, Z.A., Dual masking of specific negative splicing regulatory elements resulted in maximal exon 7 inclusion of SMN2 gene. Mol. Ther. 22 (2014), 854–861.
183. [183] Rogalska, M.E., Tajnik, M., Licastro, D., Bussani, E., Camparini, L., Mattioli, C., Pagani, F., Therapeutic activity of modified U1 core spliceosomal particles. Nat. Commun., 4, 2016, 11168.
184. [184] Muñoz, M.J., de la Mata, M., Kornblihtt, A.R., The carboxy terminal domain of RNA polymerase II and alternative splicing. Trends Biochem. Sci. 35 (2010), 497–504.
185. [185] Saldi, T., Cortazar, M.A., Sheridan, R.M., Bentley, D.L., Coupling of RNA polymerase II transcription elongation with pre-mRNA splicing. J. Mol. Biol. 428 (2016), 2623–2635.
186. [186] Yamazaki, T., Chen, S., Yu, Y., Yan, B., Haertlein, T.C., Carrasco, M.A., Tapia, J.C., Zhai, B., Das, R., Lalancette-Hebert, M., Sharma, A., Chandran, S., Sullivan, G., Nishimura, A.L., Shaw, C.E., Gygi, S.P., Shneider, N.A., Maniatis, T., Reed, R., FUS-SMN protein interactions link the motor neuron diseases ALS and SMA. Cell Rep. 25 (2012), 799–806.
187. [187] Pellizzoni, L., Charroux, B., Rappsilber, J., Mann, M., Dreyfuss, G., A functional interaction between the survival motor neuron complex and RNA polymerase II. J. Cell Biol. 152 (2001), 75–85.
188. [188] Strasswimmer, J., Lorson, C.L., Breiding, D.E., Chen, J.J., Le, T., Burghes, A.H., Androphy, E.J., Identification of survival motor neuron as a transcriptional activator-binding protein. Hum. Mol. Genet. 8 (1999), 1219–1226.
189. [189] Grzenda, A., Lomberk, G., Zhang, J.S., Urrutia, R., Sin3: master scaffold and transcriptional corepressor. Biochim. Biophys. Acta 1789 (2009), 443–450.
190. [190] Almada, A.E., Wu, X., Kriz, A.J., Burge, C.B., Sharp, P.A., Promoter directionality is controlled by U1 snRNP and polyadenylation signals. Nature 499 (2013), 360–363.
191. [191] Suraweera, A., Lim, Y., Woods, R., Birrell, G.W., Nasim, T., Becherel, O.J., Lavin, M.F., Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Hum. Mol. Genet. 18 (2009), 3384–3396.
192. [192] Bronicki, L.M., Jasmin, B.J., Emerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction. RNA 19 (2013), 1019–1037.
193. [193] Kim, H.H., Lee, S.J., Gardiner, A.S., Perrone-Bizzozero, N.I., Yoo, S., Different motif requirements for the localization zipcode element of β-actin mRNA binding by HuD and ZBP1. Nucleic Acids Res. 43 (2015), 7432–7446.
194. [194] Farooq, F., Balabanian, S., Liu, X., Holcik, M., MacKenzie, A., p38 mitogen-activated protein kinase stabilizes SMN mRNA through RNA binding protein HuR. Hum. Mol. Genet. 18 (2009), 4035–4045.
195. [195] Keenan, R.J., Freymann, D.M., Stroud, R.M., Walter, P., The signal recognition particle. Annu. Rev. Biochem. 70 (2001), 755–775.
196. [196] Saraogi, I., Shan, S.O., Molecular mechanism of co-translational protein targeting by the signal recognition particle. Traffic 12 (2011), 535–542.
197. [197] Cheng, D., Côté, J., Shaaban, S., Bedford, M.T., The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol. Cell 25 (2007), 71–83.
198. [198] Sims, R.J. III, Rojas, L.A., Beck, D., Bonasio, R., Schüller, R., Drury, W.J. III, Eick, D., Reinberg, D., The C-terminal domain of RNA polymerase II is modified by site-specific methylation. Science 332 (2011), 99–103.
199. [199] Shin, H.J., Kim, H., Oh, S., Lee, J.G., Kee, M., Ko, H.J., Kweon, M.N., Won, K.J., Baek, S.H., AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature 534 (2016), 553–557.
200. [200] Liu, H., Shafey, D., Moores, J.N., Kothary, R., Neurodevelopmental consequences of Smn depletion in a mouse model of spinal muscular atrophy. J. Neurosci. Res. 88 (2010), 111–122.
201. [201] Kye, M.J., Niederst, E.D., WertZ, M.H., Gonçalves Ido, C., Akten, B., Dover, K.Z., Peters, M., Riessland, M., Neveu, P., Wirth, B., Kosik, K.S., Sardi, S.P., Monani, U.R., Passini, M.A., Sahin, M., SMN regulates axonal local translation via miR-183/mTOR pathway. Hum. Mol. Genet. 23 (2014), 6318–6331.
202. [202] Wang, L.T., Chiou, S.S., Liao, Y.M., Jong, Y.J., Hsu, S.H., Survival of motor neuron protein downregulates miR-9 expression in patients with spinal muscular atrophy. Kaohsiung J. Med. Sci. 30 (2014), 229–234.
203. [203] Luchetti, A., Ciafrè, S.A., Murdocca, M., Malgieri, A., Masotti, A., Sanchez, M., Farace, M.G., Novelli, G., Sangiuolo, F., A perturbed microRNA expression pattern characterizes embryonic neural stem cells derived from a severe mouse model of spinal muscular atrophy (SMA). Int. J. Mol. Sci. 16 (2015), 18312–18327.
204. [204] Catapano, F., Zaharieva, I., Scoto, M., Marrosu, E., Morgan, J., Muntoni, F., Zhou, H., Altered levels of microRNA-9, -206, and -132 in spinal muscular atrophy and their response to antisense oligonucleotide therapy. Mol. Ther.–Nucleic Acids, 5, 2016, e331.
205. [205] Wertz, M.H., Winden, K., Neveu, P., Ng, S.Y., Ercan, E., Sahin, M., Cell-type-specific miR-431 dysregulation in a motor neuron model of spinal muscular atrophy. Hum. Mol. Genet. 25 (2016), 2168–2181.
206. [206] Driscoll, D.M., Copeland, P.R., Mechanism and regulation of selenoprotein synthesis. Annu. Rev. Nutr. 23 (2003), 17–40.
207. [207] Labunskyy, V.M., Hatfield, D.L., Gladyshev, V.N., Selenoproteins: molecular pathways and physiological roles. Physiol. Rev. 94 (2014), 739–777.
208. [208] Papp, L.V., Wang, J., Kennedy, D., Boucher, D., Zhang, Y., Gladyshev, V.N., Singh, R.N., Khanna, K.K., Functional characterization of alternatively spliced human SECISBP2 transcript variants. Nucleic Acids Res. 36 (2008), 7192–7206.
209. [209] Papp, L.V., Lu, J., Bolderson, E., Boucher, D., Singh, R., Holmgren, A., Khanna, K.K., SECIS-binding protein 2 promotes cell survival by protecting against oxidative stress. Antioxid. Redox Signal. 12 (2010), 797–808.
210. [210] Protter, D.S., Parker, R., Principles and properties of stress granules. Trends Cell Biol. 26 (2016), 668–679.
211. [211] Anderson, P., Kedersha, N., Ivanov, P., Stress granules, P-bodies and cancer. Biochim. Biophys. Acta 1849 (2015), 861–870.
212. [212] Vanderweyde, T., Youmans, K., Liu-Yesucevitz, L., Wolozin, B., Role of stress granules and RNA-binding proteins in neurodegeneration: a mini-review. Gerontology 59 (2013), 524–533.
213. [213] Monahan, Z., Shewmaker, F., Pandey, U.B., Stress granules at the intersection of autophagy and ALS. Brain Res. 1649 (2016), 189–200.
214. [214] Linder, B., Plöttner, O., Kroiss, M., Hartmann, E., Laggerbauer, B., Meister, G., Keidel, E., Fischer, U., Tdrd3 is a novel stress granule-associated protein interacting with the Fragile-X syndrome protein FMRP. Hum. Mol. Genet. 17 (2008), 3236–3246.
215. [215] Singh, N.N., Seo, J., Ottesen, E.W., Shishimorova, M., Bhattacharya, D., Singh, R.N., TIA1 prevents skipping of a critical exon associated with spinal muscular atrophy. Mol. Cell. Biol. 1 (2011), 935–954.
216. [216] Ceccaldi, R., Rondinelli, B., D'Andrea, A.D., Repair pathway choices and consequences at the double-strand break. Trends Cell Biol. 26 (2016), 52–64.
217. [217] Tham, K.C., Kanaar, R., Lebbink, J.H., Mismatch repair and homeologous recombination. DNA Repair 38 (2016), 75–83.
218. [218] Hunter, N., Meiotic recombination: the essence of heredity. Cold Spring Harb. Perspect. Biol., 7, 2015 (pii: a016618).
219. [219] Godin, S.K., Sullivan, M.R., Bernstein, K.A., Novel insights into RAD51 activity and regulation during homologous recombination and DNA replication. Biochem. Cell Biol. 94 (2016), 407–418.
220. [220] Gupta, R.C., Bazemore, L.R., Golub, E.I., Radding, C.M., Activities of human recombination protein Rad51. Proc. Natl. Acad. Sci. U. S. A. 94 (1997), 463–468.
221. [221] Takizawa, Y., Qing, Y., Takaku, M., Ishida, T., Morozumi, Y., Tsujita, T., Kogame, T., Hirota, K., Takahashi, M., Shibata, T., Kurumizaka, H., Takeda, S., GEMIN2 promotes accumulation of RAD51 at double-strand breaks in homologous recombination. Nucleic Acids Res. 38 (2010), 5059–5074.
222. [222] Morozumi, Y., Takizawa, Y., Takaku, M., Kurumizaka, H., Human PSF binds to RAD51 and modulates its homologous-pairing and strand-exchange activities. Nucl. Acids Res. 37 (2009), 4296–4307.
223. [223] Stirling, P.C., Hieter, P., Canonical DNA repair pathways influence R-loop-driven genome instability. J. Mol. Biol., 2016, 10.1016/j.jmb.2013.07.014.
224. [224] Moses, R.E., O'Malley, B.W., DNA transcription and repair: a confluence. J. Biol. Chem. 287 (2012), 23266–23270.
225. [225] Fayzullina, S., Martin, L.J., Skeletal muscle DNA damage precedes spinal motor neuron DNA damage in a mouse model of Spinal Muscular Atrophy (SMA). PLoS One, 9, 2014, e93329.
226. [226] Kahn, O.I., Baas, P.W., Microtubules and growth cones: motors drive the turn. Trends Neurosci. 39 (2016), 433–440.
227. [227] Fan, L., Simard, L.R., Survival motor neuron (SMN) protein: role in neurite outgrowth and neuromuscular maturation during neuronal differentiation and development. Hum. Mol. Genet. 11 (2002), 1605–1614.
228. [228] Nölle, A., Zeug, A., van Bergeijk, J., Tönges, L., Gerhard, R., Brinkmann, H., Al Rayes, S., Hensel, N., Schill, Y., Apkhazava, D., Jablonka, S., O'mer, J., Srivastav, R.K., Baasner, A., Lingor, P., Wirth, B., Ponimaskin, E., Niedenthal, R., Grothe, C., Claus, P., The spinal muscular atrophy disease protein SMN is linked to the Rho-kinase pathway via profilin. Hum. Mol. Genet. 20 (2011), 4865–4878.
229. [229] Bowerman, M., Shafey, D., Kothary, R., Smn depletion alters profilin II expression and leads to upregulation of the RhoA/ROCK pathway and defects in neuronal integrity. J. Mol. Neurosci. 32 (2007), 120–131.
230. [230] Da Silva, J.S., Medina, M., Zuliani, C., Di Nardo, A., Witke, W., Dotti, C.G., RhoA/ROCK regulation of neuritogenesis via profilin IIa-mediated control of actin stability. J. Cell Biol. 162 (2003), 1267–1279.
231. [231] Genabai, N.K., Ahmad, S., Zhang, Z., Jiang, X., Gabaldon, C.A., Gangwani, L., Genetic inhibition of JNK3 ameliorates spinal muscular atrophy. Hum. Mol. Genet. 24 (2015), 6986–7004.
232. [232] Wishart, T.M., Mutsaers, C.A., Riessland, M., Reimer, M.M., Hunter, G., Hannam, M.L., Eaton, S.L., Fuller, H.R., Roche, S.L., Somers, E., Morse, R., Young, P.J., Lamont, D.J., Hammerschmidt, M., Joshi, A., Hohenstein, P., Morris, G.E., Parson, S.H., Skehel, P.A., Becker, T., Robinson, I.M., Becker, C.G., Wirth, B., Gillingwater, T.H., Dysregulation of ubiquitin homeostasis and β-catenin signaling promote spinal muscular atrophy. J. Clin. Invest. 124 (2014), 1821–1834.
233. [233] Bowerman, M., Beauvais, A., Anderson, C.L., Kothary, R., Rho-kinase inactivation prolongs survival of an intermediate SMA mouse model. Hum. Mol. Genet. 19 (2010), 1468–1478.
234. [234] Bowerman, M., Murray, L.M., Boyer, J.G., Anderson, C.L., Kothary, R., Fasudil improves survival and promotes skeletal muscle development in a mouse model of spinal muscular atrophy. BMC Med., 10, 2012, 24.
235. [235] Delanote, V., Vandekerckhove, J., Gettemans, J., Plastins: versatile modulators of actin organization in (patho)physiological cellular processes. Acta Pharmacol. Sin. 26 (2005), 769–779.
236. [236] Giganti, A., Plastino, J., Janji, B., Van Troys, M., Lentz, D., Ampe, C., Sykes, C., Friederich, E., Actin-filament cross-linking protein T-plastin increases Arp2/3-mediated actin-based movement. J. Cell Sci. 118 (2005), 1255–1265.
237. [237] Heesen, L., Peitz, M., Torres-Benito, L., Hölker, I., Hupperich, K., Dobrindt, K., Jungverdorben, J., Ritzenhofen, S., Weykopf, B., Eckert, D., Hosseini-Barkooie, S.M., Storbeck, M., Fusaki, N., Lonigro, R., Heller, R., Kye, M.J., Brüstle, O., Wirth, B., Plastin 3 is upregulated in iPSC-derived motoneurons from asymptomatic SMN1-deleted individuals. Cell. Mol. Life Sci. 73 (2016), 2089–2104.
238. [238] Bowerman, M., Anderson, C.L., Beauvais, A., Boyl, P.P., Witke, W., Kothary, R., SMN, profilin IIa and plastin 3: a link between the deregulation of actin dynamics and SMA pathogenesis. Mol. Cell. Neurosci. 42 (2009), 66–74.
239. [239] Ackermann, B., Kröber, S., Torres-Benito, L., Borgmann, A., Peters, M., Hosseini Barkooie, S.M., Tejero, R., Jakubik, M., Schreml, J., Milbradt, J., Wunderlich, T.F., Riessland, M., Tabares, L., Wirth, B., Plastin 3 ameliorates spinal muscular atrophy via delayed axon pruning and improves neuromuscular junction functionality. Hum. Mol. Genet. 22 (2013), 1328–1347.
240. [240] McGovern, V.L., Massoni-Laporte, A., Wang, X., Le, T.T., Le, H.T., Beattie, C.E., Rich, M.M., Burghes, A.H.M., Plastin 3 expression does not modify spinal muscular atrophy severity in the ∆ 7 SMA mouse. PLoS One, 10, 2015, e0132364.
241. [241] Hosseinibarkooie, S., Peters, M., Torres-Benito, L., Rastetter, R.H., Hupperich, K., Hoffmann, A., Mendoza-Ferreira, N., Kaczmarek, A., Janzen, E., Milbradt, J., Lamkemeyer, T., Rigo, F., Bennett, C.F., Guschlbauer, C., Büschges, A., Hammerschmidt, M., Riessland, M., Kye, M.J., Clemen, C.S., Wirth, B., The power of human protective modifiers: PLS3 and CORO1C unravel impaired endocytosis in spinal muscular atrophy and rescue SMA phenotype. Am. J. Hum. Genet. 99 (2016), 647–665.
242. [242] Korhonen, L., Lindholm, D., The ubiquitin proteasome system in synaptic and axonal degeneration: a new twist to an old cycle. J. Cell Biol. 165 (2004), 27–30.
243. [243] Chang, H.-C., Hung, W.-C., Chuang, Y.-J., Jong, Y.-J., Degradation of survival motor neuron (SMN) protein is mediated via the ubiquitin/proteasome pathway. Neurochem. Int. 45 (2004), 1107–1112.
244. [244] Hsu, S.-H., Lai, M.-C., Er, T.-K., Yang, S.-N., Hung, C.-H., Tsai, H.-H., Lin, Y.-C., Chang, J.-G., Lo, Y.-C., Jong, Y.-J., Ubiquitin carboxyl-terminal hydrolase L1 (UCHL1) regulates the level of SMN expression through ubiquitination in primary spinal muscular atrophy fibroblasts. Clin. Chim. Acta 411 (2010), 1920–1928.
245. [245] Sen, A., Yokokura, T., Kankel, M.W., Dimlich, D.N., Manent, J., Sanyal, S., Artavanis-Tsakonas, S., Modeling spinal muscular atrophy in Drosophila links Smn to FGF signaling. J. Cell Biol. 192 (2011), 481–495.
246. [246] Beck, R., Ravet, M., Weiland, F.T., Cassel, D., The COPI system: molecular mechanisms and function. FEBS Lett. 583 (2009), 2701–2709.
247. [247] Custer, S.K., Todd, A.G., Singh, N.N., Androphy, E.J., Dilysine motifs in exon 2b of SMN protein mediate binding to the COPI vesicle protein α-COP and neurite outgrowth in a cell culture model of spinal muscular atrophy. Hum. Mol. Genet. 22 (2013), 4043–4052.
248. [248] Li, H., Custer, S.K., Gilson, T., Hao, L.T., Beattie, C.E., Androphy, E.J., α-COP binding to the survival motor neuron protein SMN is required for neuronal process outgrowth. Hum. Mol. Genet. 24 (2015), 7295–7307.
249. [249] Gabanella, F., Pisani, C., Borreca, A., Farioli-Vecchioli, S., Ciotti, M.T., Ingegnere, T., Onori, A., Ammassari-Teule, M., Corbi, N., Canu, L.M., Passananti, C., Di Certo, M.G., SMN affects membrane remodelling and anchoring of the protein synthesis machinery. J. Cell Sci. 129 (2016), 804–816.
250. [250] Doherty, G.J., McMahon, H.T., Mechanisms of endocytosis. Annu. Rev. Biochem. 78 (2009), 857–902.
251. [251] Engqvist-Goldstein, A.E.Y., Drubin, D.G., Actin assembly and endocytosis: from yeast to mammals. Annu. Rev. Cell Dev. Biol. 19 (2003), 287–332.
252. [252] Dimitriadi, M., Derdowski, A., Kalloo, G., Maginnis, M.S., O'Hern, P., Bliska, B., Sorkaç, A., Nguyen, K.C.Q., Cook, S.J., Poulogiannis, G., Atwood, W.J., Hall, D.H., Hart, A.C., Decreased function of survival motor neuron protein impairs endocytic pathways. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), E4377–E4386.
253. [253] Chan, K.T., Roadcap, D.W., Holoweckyj, N., Bear, J.E., Coronin 1C harbours a second actin-binding site that confers co-operative binding to F-actin. Biochem. J. 444 (2012), 89–96.
254. [254] Pelkmans, L., Helenius, A., Endocytosis via caveolae. Traffic 3 (2002), 311–320.
255. [255] Mizushima, N., Levine, B., Cuervo, A.M., Klionsky, D.J., Autophagy fights disease through cellular self-digestion. Nature 451 (2008), 1069–1075.
256. [256] Morimoto, N., Nagai, M., Ohta, Y., Miyazaki, K., Kurata, T., Morimoto, M., Murakami, T., Takehisa, Y., Ikeda, Y., Kamiya, T., Abe, K., Increased autophagy in transgenic mice with a G93A mutant SOD1 gene. Brain Res. 1167 (2007), 112–117.
257. [257] Li, L., Zhang, X., Le, W., Altered macroautophagy in the spinal cord of SOD1 mutant mice. Autophagy 4 (2008), 290–293.
258. [258] Garcera, A., Bahi, N., Periyakaruppiah, A., Arumugam, S., Soler, R.M., Survival motor neuron protein reduction deregulates autophagy in spinal cord motoneurons in vitro. Cell Death Dis., 4, 2013, e686.
259. [259] Custer, S.K., Androphy, E.J., Autophagy dysregulation in cell culture and animals models of spinal muscular atrophy. Mol. Cell. Neurosci. 61 (2014), 133–140.
260. [260] Wen, H.-L., Lin, Y.-T., Ting, C.-H., Lin-Chao, S., Li, H., Hsieh-Li, H.M., Stathmin, a microtubule-destabilizing protein, is dysregulated in spinal muscular atrophy. Hum. Mol. Genet. 19 (2010), 1766–1778.
261. [261] Periyakaruppiah, A., de la Fuente, S., Arumugam, S., Bahí, N., Garcera, A., Soler, R.M., Autophagy modulators regulate survival motor neuron protein stability in motoneurons. Exp. Neurol. 283 (2016), 287–297.
262. [262] Edens, B.M., Ajroud-Driss, S., Ma, L., Ma, Y.-C., Molecular mechanisms and animal models of spinal muscular atrophy. Biochim. Biophys. Acta 1852 (2015), 685–692.
263. [263] Sleigh, J.N., Buckingham, S.D., Esmaeili, B., Viswanathan, M., Cuppen, E., Westlund, B.M., Sattelle, D.B., A novel Caenorhabditis elegans allele, smn-1(cb131), mimicking a mild form of spinal muscular atrophy, provides a convenient drug screening platform highlighting new and pre-approved compounds. Hum. Mol. Genet. 20 (2011), 245–260.
264. [264] Chan, Y.B., Miguel-Aliaga, I., Franks, C., Thomas, N., Trülzsch, B., Sattelle, D.B., Davies, K.E., van den Heuvel, M., Neuromuscular defects in a Drosophila survival motor neuron gene mutant. Hum. Mol. Genet. 12 (2003), 1367–1376.
265. [265] Praveen, K., Wen, Y., Gray, K.M., Noto, J.J., Patlolla, A.R., Van Duyne, G.D., Matera, A.G., SMA-causing missense mutations in survival motor neuron (Smn) display a wide range of phenotypes when modeled in Drosophila. PLoS Genet., 10, 2014, e1004489.
266. [266] Praveen, K., Wen, Y., Matera, A.G., A Drosophila model of spinal muscular atrophy uncouples snRNP biogenesis functions of survival motor neuron from locomotion and viability defects. Cell Rep. 1 (2012), 624–631.
267. [267] McWhorter, M.L., Monani, U.R., Burghes, A.H.M., Beattie, C.E., Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162 (2003), 919–931.
268. [268] Boon, K.-L., Xiao, S., McWhorter, M.L., Donn, T., Wolf-Saxon, E., Bohnsack, M.T., Moens, C.B., Beattie, C.E., Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Hum. Mol. Genet. 18 (2009), 3615–3625.
269. [269] Hsieh-Li, H.M., Chang, J.G., Jong, Y.J., Wu, M.H., Wang, N.M., Tsai, C.H., Li, H., A mouse model for spinal muscular atrophy. Nat. Genet. 24 (2000), 66–70.
270. [270] McGovern, V.L., Gavrilina, T.O., Beattie, C.E., Burghes, A.H.M., Embryonic motor axon development in the severe SMA mouse. Hum. Mol. Genet. 17 (2008), 2900–2909.
271. [271] Kariya, S., Park, G.-H., Maeno-Hikichi, Y., Leykekhman, O., Lutz, C., Arkovitz, M.S., Landmesser, L.T., Monani, U.R., Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 17 (2008), 2552–2569.
272. [272] Kong, L., Wang, X., Choe, D.W., Polley, M., Burnett, B.G., Bosch-Marcé, M., Griffin, J.W., Rich, M.M., Sumner, C.J., Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci. 29 (2009), 842–851.
273. [273] Kariya, S., Obis, T., Garone, C., Akay, T., Sera, F., Iwata, S., Homma, S., Monani, U.R., Requirement of enhanced survival motoneuron protein imposed during neuromuscular junction maturation. J. Clin. Invest. 124 (2014), 785–800.
274. [274] Zhang, Z., Pinto, A.M., Wan, L., Wang, W., Berg, M.G., Oliva, I., Singh, L.N., Dengler, C., Wei, Z., Dreyfuss, G., Dysregulation of synaptogenesis genes antecedes motor neuron pathology in spinal muscular atrophy. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 19348–19353.
275. [275] Bebee, T.W., Dominguez, C.E., Chandler, D.S., Mouse models of SMA: tools for disease characterization and therapeutic development. Hum. Genet. 131 (2012), 1277–1293.
276. [276] Shababi, M., Habibi, J., Yang, H.T., Vale, S.M., Sewell, W.A., Lorson, C.L., Cardiac defects contribute to the pathology of spinal muscular atrophy models. Hum. Mol. Genet. 19 (2010), 4059–4071.
277. [277] Heier, C.R., Satta, R., Lutz, C., DiDonato, C.J., Arrhythmia and cardiac defects are a feature of spinal muscular atrophy model mice. Hum. Mol. Genet. 19 (2010), 3906–3918.
278. [278] Schreml, J., Riessland, M., Paterno, M., Garbes, L., Roßbach, K., Ackermann, B., Krämer, J., Somers, E., Parson, S.H., Heller, R., Berkessel, A., Sterner-Kock, A., Wirth, B., Severe SMA mice show organ impairment that cannot be rescued by therapy with the HDACi JNJ-26481585. Eur. J. Hum. Genet. 21 (2013), 643–652.
279. [279] Michaud, M., Arnoux, T., Bielli, S., Durand, E., Rotrou, Y., Jablonka, S., Robert, F., Giraudon-Paoli, M., Riessland, M., Mattei, M.-G., Andriambeloson, E., Wirth, B., Sendtner, M., Gallego, J., Pruss, R.M., Bordet, T., Neuromuscular defects and breathing disorders in a new mouse model of spinal muscular atrophy. Neurobiol. Dis. 38 (2010), 125–135.
280. [280] Shanmugarajan, S., Tsuruga, E., Swoboda, K.J., Maria, B.L., Ries, W.L., Reddy, S.V., Bone loss in survival motor neuron (Smn(−/−) SMN2) genetic mouse model of spinal muscular atrophy. J. Pathol. 219 (2009), 52–60.
281. [281] Gombash, S.E., Cowley, C.J., Fitzgerald, J.A., Iyer, C.C., Fried, D., McGovern, V.L., Williams, K.C., Burghes, A.H.M., Christofi, F.L., Gulbransen, B.D., Foust, K.D., SMN deficiency disrupts gastrointestinal and enteric nervous system function in mice. Hum. Mol. Genet. 24 (2015), 3847–3860.
282. [282] Sintusek, P., Catapano, F., Angkathunkayul, N., Marrosu, E., Parson, S.H., Morgan, J.E., Muntoni, F., Zhou, H., Histopathological defects in intestine in severe spinal muscular atrophy mice are improved by systemic antisense oligonucleotide treatment. PLoS One, 11, 2016, e0155032.
283. [283] Vitte, J.M., Davoult, B., Roblot, N., Mayer, M., Joshi, V., Courageot, S., Tronche, F., Vadrot, J., Moreau, M.H., Kemeny, F., Melki, J., Deletion of murine Smn exon 7 directed to liver leads to severe defect of liver development associated with iron overload. Am. J. Pathol. 165 (2004), 1731–1741.
284. [284] Szunyogova, E., Zhou, H., Maxwell, G.K., Powis, R.A., Francesco, M., Gillingwater, T.H., Parson, S.H., Survival Motor Neuron (SMN) protein is required for normal mouse liver development. Sci. Rep., 6, 2016, 34635.
285. [285] Bowerman, M., Swoboda, K.J., Michalski, J.-P., Wang, G.-S., Reeks, C., Beauvais, A., Murphy, K., Woulfe, J., Screaton, R.A., Scott, F.W., Kothary, R., Glucose metabolism and pancreatic defects in spinal muscular atrophy. Ann. Neurol. 72 (2012), 256–268.
286. [286] Thomson, A.K., Somers, E., Powis, R.A., Shorrock, H.K., Murphy, K., Swoboda, K.J., Gillingwater, T.H., Parson, S.H., Survival of motor neurone protein is required for normal postnatal development of the spleen. J. Anat., 2016, 10.1111/joa.12546.
287. [287] Eshraghi, M., McFall, E., Gibeault, S., Kothary, R., Effect of genetic background on the phenotype of the Smn2B/− mouse model of spinal muscular atrophy. Hum. Mol. Genet., Aug 18 2016, 10.1093/hmg/ddw278 (pii: ddw278).